L-Alprenolol | CAS#23846-71-1 | beta blocker

MedKoo Cat#: 596849 | Name: L-Alprenolol

Description:

WARNING: This product is for research use only, not for human or veterinary use.

L-Alprenolol is a non-selective beta blocker as well as a 5-HT1A and 5-HT1B receptor antagonist, used in the treatment of angina pectoris.

Chemical Structure

L-Alprenolol

CAS#23846-71-1

Theoretical Analysis

MedKoo Cat#: 596849

Name: L-Alprenolol

CAS#: 23846-71-1

Chemical Formula: C15H23NO2

Exact Mass: 249.1729

Molecular Weight: 249.35

Elemental Analysis: C, 72.25; H, 9.30; N, 5.62; O, 12.83

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

L-Alprenolol; (-)-Alprenolol; (S)-Alprenolol;

IUPAC/Chemical Name

1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol

InChi Key

PAZJSJFMUHDSTF-UHFFFAOYSA-N

InChi Code

InChI=1S/C15H23NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h4-6,8-9,12,14,16-17H,1,7,10-11H2,2-3H3

SMILES Code

OC(COC1=CC=CC=C1CC=C)CNC(C)C

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 249.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Rao NV, Macchi C, Tortorella C, Ahmad MF, Nussdorfer GG. Neuropeptide Y and glucocorticoid secretion from guinea pig adrenal gland: an in vivo and in vitro study. Int J Mol Med. 2007 Sep;20(3):345-9. PubMed PMID: 17671739. 2: Andreis PG, Tortorella C, Ziolkowska A, Spinazzi R, Malendowicz LK, Neri G, Nussdorfer GG. Evidence for a paracrine role of endogenous adrenomedullary galanin in the regulation of glucocorticoid secretion in the rat adrenal gland. Int J Mol Med. 2007 Mar;19(3):511-5. PubMed PMID: 17273801. 3: Hochol A, Tortorella C, Ricinski M, Ziolkowska A, Nussdorfer GG, Malendowicz LK. Effects of neuropeptides B and W on the rat pituitary-adrenocortical axis: in vivo and in vitro studies. Int J Mol Med. 2007 Feb;19(2):207-11. PubMed PMID: 17203193. 4: Raha D, Tortorella C, Neri G, Prasad A, Raza B, Raskar R, Dubey R, Sen NS, Macchi C, Malendowicz LK, Ahmad MF, Nussdorfer GG. Atrial natriuretic peptide enhances cortisol secretion from guinea-pig adrenal gland: evidence for an indirect paracrine mechanism probably involving the local release of medullary catecholamines. Int J Mol Med. 2006 Apr;17(4):633-6. PubMed PMID: 16525720. 5: Albertin G, Malendowicz LK, Tortorella C, Mazzocchi G, Nussdorfer GG. Evidence for a paracrine role of adrenomedullin in the physiological resetting of aldosterone secretion by rat adrenal zona glomerulosa. Peptides. 2000 Mar;21(3):413-7. PubMed PMID: 10793225. 6: Albertin G, Malendowicz LK, Macchi C, Markowska A, Nussdorfer GG. Cerebellin stimulates the secretory activity of the rat adrenal gland: in vitro and in vivo studies. Neuropeptides. 2000 Feb;34(1):7-11. PubMed PMID: 10688962. 7: Rebuffat P, Macchi C, Malendowicz LK, Nussdorfer GG. Comparison of the signaling mechanisms involved in the ETB receptor-mediated secretagogue action of endothelin-1 on dispersed zona glomerulosa cells and capsule-zona glomerulosa preparations of the rat adrenal gland. Int J Mol Med. 2000 Jan;5(1):43-7. PubMed PMID: 10601572. 8: Rebuffat P, Mazzocchi G, Macchi C, Malendowicz LK, Gottardo G, Nussdorfer GG. Mechanisms and receptor subtypes involved in the stimulatory action of endothelin-1 on rat adrenal zona glomerulosa. Int J Mol Med. 1999 Mar;3(3):307-10. PubMed PMID: 10028057. 9: Mazzocchi G, Andreis PG, De Caro R, Aragona F, Gottardo L, Nussdorfer GG. Cerebellin enhances in vitro secretory activity of human adrenal gland. J Clin Endocrinol Metab. 1999 Feb;84(2):632-5. PubMed PMID: 10022429. 10: Misane I, Johansson C, Ogren SO. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat. Br J Pharmacol. 1998 Oct;125(3):499-509. PubMed PMID: 9806333; PubMed Central PMCID: PMC1565647. 11: Mazzocchi G, Gottardo G, Macchi V, Malendowicz LK, Nussdorfer GG. The AT2 receptor-mediated stimulation of adrenal catecholamine release may potentiate the AT1 receptor-mediated aldosterone secretagogue action of angiotensin-II in rats. Endocr Res. 1998 Feb;24(1):17-28. PubMed PMID: 9553752. 12: Andreis PG, Neri G, Prayer-Galetti T, Rossi GP, Gottardo G, Malendowicz LK, Nussdorfer GG. Effects of adrenomedullin on the human adrenal glands: an in vitro study. J Clin Endocrinol Metab. 1997 Apr;82(4):1167-70. PubMed PMID: 9100590. 13: Nussdorfer GG, Rossi GP, Mazzocchi G. Role of adrenomedullin and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides. 1997;18(7):1079-89. Review. PubMed PMID: 9357070. 14: Mazzocchi G, Musajo F, Neri G, Gottardo G, Nussdorfer GG. Adrenomedullin stimulates steroid secretion by the isolated perfused rat adrenal gland in situ: comparison with calcitonin gene-related peptide effects. Peptides. 1996;17(5):853-7. PubMed PMID: 8844777. 15: Neri G, Andreis PG, Prayer-Galetti T, Rossi GP, Malendowicz LK, Nussdorfer GG. Pituitary adenylate-cyclase activating peptide enhances aldosterone secretion of human adrenal gland: evidence for an indirect mechanism, probably involving the local release of catecholamines. J Clin Endocrinol Metab. 1996 Jan;81(1):169-73. PubMed PMID: 8550747. 16: Andreis PG, Malendowicz LK, Belloni AS, Nussdorfer GG. Effects of pituitary adenylate-cyclase activating peptide (PACAP) on the rat adrenal secretory activity: preliminary in-vitro studies. Life Sci. 1995;56(2):135-42. PubMed PMID: 7823760. 17: Mazzocchi G, Malendowicz LK, Belloni AS, Nussdorfer GG. Adrenal medulla is involved in the aldosterone secretagogue effect of substance P. Peptides. 1995;16(2):351-5. PubMed PMID: 7540295. 18: Bjorvatn B, Neckelmann D, Ursin R. The 5-HT1A antagonist (-)-alprenolol fails to modify sleep or zimeldine-induced sleep-waking effects in rats. Pharmacol Biochem Behav. 1992 May;42(1):49-56. PubMed PMID: 1388278. 19: Ghahary A, Cheng KW. Identification and characterization of the beta-adrenergic receptor on neuroblastoma x glioma hybrid NG108-15 cells. Cell Mol Neurobiol. 1990 Sep;10(3):337-50. PubMed PMID: 2174741. 20: Segal J, Ingbar SH. Evidence that an increase in cytoplasmic calcium is the initiating event in certain plasma membrane-mediated responses to 3,5,3'-triiodothyronine in rat thymocytes. Endocrinology. 1989 Apr;124(4):1949-55. PubMed PMID: 2538316.